SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $203 | $305 | $132 | $900 |
| - Cash | $80 | $123 | $161 | $193 |
| + Debt | $30 | $19 | $17 | $13 |
| Enterprise Value | $153 | $200 | -$13 | $720 |
| Revenue | $65 | $62 | $48 | $40 |
| % Growth | 4.5% | 31.1% | 17.6% | – |
| Gross Profit | $44 | $43 | $31 | $25 |
| % Margin | 67.4% | 68.8% | 65.7% | 62.4% |
| EBITDA | -$51 | -$70 | -$81 | -$69 |
| % Margin | -77.9% | -111.5% | -171.1% | -171.2% |
| Net Income | -$62 | -$79 | -$87 | -$74 |
| % Margin | -95.9% | -126.6% | -183.9% | -182.1% |
| EPS Diluted | -0.95 | -1.22 | -1.36 | -1.33 |
| % Growth | 22.1% | 10.3% | -2.3% | – |
| Operating Cash Flow | -$43 | -$49 | -$70 | -$58 |
| Capital Expenditures | -$8 | -$9 | -$10 | -$7 |
| Free Cash Flow | -$51 | -$58 | -$80 | -$65 |